PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+3.03%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$751M
AUM Growth
-$32.5M
(-4.2%)
Cap. Flow
+$3.19M
Cap. Flow
% of AUM
0.42%
Top 10 Holdings %
Top 10 Hldgs %
35.59%
Holding
104
New
11
Increased
46
Reduced
31
Closed
15
Top Buys
| 1 |
Gilead Sciences
GILD
|
$22.7M |
| 2 |
Stryker
SYK
|
$17.9M |
| 3 |
McKesson
MCK
|
$13.1M |
| 4 |
Viridian Therapeutics
VRDN
|
$12.7M |
| 5 |
Edwards Lifesciences
EW
|
$10.8M |
Top Sells
| 1 |
Teleflex
TFX
|
$23.8M |
| 2 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$16.4M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.7M |
| 4 |
Boston Scientific
BSX
|
$9.81M |
| 5 |
Eli Lilly
LLY
|
$9.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
X4 Pharmaceuticals
XFOR
$70M
| – | – |
-27,291
| Closed | -$548K |
|
|
LENZ
102
LENZ Therapeutics
LENZ
$1.12B
| – | – |
-139,357
| Closed | -$3.31M |
|
|
CDMO
103
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-719,965
| Closed | -$8.19M |
|
|
LBPH
104
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-491,272
| Closed | -$16.4M |
|